CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test
Introduction
The CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test is a specialized genetic test designed to identify mutations in the CDKN2A gene, which is associated with an increased risk of developing pancreatic cancer and melanoma. Understanding your genetic predisposition can empower you and your healthcare provider to make informed decisions regarding your health management and cancer prevention strategies.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to detect specific mutations in the CDKN2A gene. By analyzing your DNA, the test provides crucial insights into your risk for developing hereditary pancreatic cancer and melanoma.
Who Should Consider This Test?
This test is recommended for individuals who:
- Have a family history of pancreatic cancer or melanoma.
- Exhibit symptoms associated with these cancers.
- Are concerned about their genetic risk factors.
Consultation with an oncologist or a genetic counselor is advised to assess the appropriateness of this test based on personal and family medical history.
Benefits of Taking the Test
- Early detection of genetic mutations that may lead to pancreatic cancer and melanoma.
- Informed decisions regarding surveillance and preventive measures.
- Personalized risk assessment and management strategies.
- Potential eligibility for targeted therapies or clinical trials.
Understanding Your Results
After the test is completed, your results will be reviewed by a qualified genetic counselor or oncologist. They will help you understand the implications of your results, whether you have a mutation or not, and discuss potential next steps for monitoring and management.
Test Pricing
Discount Price | Regular Price |
---|---|
400,000 NGN | 560,000 NGN |
Booking Information
To book the CDKN2A Gene Pancreatic Cancer/Melanoma Syndrome Familial NGS Genetic DNA Test, please contact us at +2348110567037. Our team is ready to assist you with the booking process and any inquiries you may have.
Test Details
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient who is going for the test is required, along with a genetic counseling session to draw a pedigree chart of family members affected with CDKN2A gene mutations.